Behind-the-Counter-Drugs: New Life for an Old Idea?

In light of recent events that have brought the idea of behind-the-counter (BTC) drugs back to the forefront at the FDA, including the agency's approval of BTC status for emergency contraceptive agent Plan B, the article examines the FDA's authority and history of practice regarding BTC drugs, as well as the future of BTC drugs.


Download PDF Share Back To Listing
Loading data